Solana Company is a publicly listed digital asset treasury that acquires and holds Solana tokens with the objective of maximizing SOL per share for shareholders through active management, including staking rewards, liquid staking arrangements, and strategic financing. The company provides public investors with direct exposure to Solana, a high-performance blockchain platform known for scalability and low-latency transaction processing, while pursuing yield-generation strategies such as native staking, institutional lending, and selected decentralized finance approaches managed through regulated U.S.-based custodians. As a secondary business, the company operates a neurotechnology division developing the PoNS, a non-implantable medical device for treating neurological conditions including gait deficits and balance disorders in patients with multiple sclerosis, stroke, and traumatic brain injury.